Biotech · Private company · Morrisville, NC, US
Vast Therapeutics, Inc.
Track this companyFree. Adds Vast Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards5
- Inhaled Nitric-Oxide Releasing Prodrug to Treat Drug Resistant Klebsiella pneumoniae InfectionsFiscal year 2026 · $1MNIH RePORTER 1R44AI191890-01A1 · fetched Nov 12, 2026
- Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patientsFiscal year 2026 · $988.6KNIH RePORTER 5R44AI184225-02 · fetched Nov 12, 2026
- Nebulized ALX1 as a Treatment for Difficult Non-tuberculous Mycobacterial Lung InfectionsFiscal year 2026 · $950.1KNIH RePORTER 5R44AI186617-02 · fetched Nov 12, 2026
- Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patientsFiscal year 2025 · $1MNIH RePORTER 1R44AI184225-01A1 · fetched Nov 12, 2026
- Nebulized ALX1 as a Treatment for Difficult Non-tuberculous Mycobacterial Lung InfectionsFiscal year 2025 · $1MNIH RePORTER 1R44AI186617-01A1 · fetched Nov 12, 2026